Cargando…
Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection
The coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China and rapidly spread in other countries in December 2019. The infected patients presented with fever, respiratory symptoms, sometimes with digestive and other systemic manifestations, and some progressed with a severe acute res...
Autores principales: | Zhang, Hui, Li, Hong-Bao, Lyu, Jian-Rui, Lei, Xiao-Ming, Li, Wei, Wu, Gang, Lyu, Jun, Dai, Zhi-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165079/ https://www.ncbi.nlm.nih.gov/pubmed/32311451 http://dx.doi.org/10.1016/j.ijid.2020.04.027 |
Ejemplares similares
-
Advances in research on ACE2 as a receptor for 2019-nCoV
por: Wu, Jie, et al.
Publicado: (2020) -
ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology
por: Guo, Yuexin, et al.
Publicado: (2021) -
Corrigendum: ACE2 in the gut: The center of the 2019-nCoV infected pathology
por: Guo, Yuexin, et al.
Publicado: (2022) -
Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus
por: Wang, Nan, et al.
Publicado: (2020) -
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
por: Xu, Hao, et al.
Publicado: (2020)